Full-Time

Director – Business Development

Medical Information Services

Posted on 12/13/2025

Deadline 2/28/26
ProPharma Group

ProPharma Group

1,001-5,000 employees

Regulatory sciences consultant for life sciences

No salary listed

Remote in USA

Remote

Category
Business & Strategy (1)
Requirements
  • Med Information Consulting sales experience and located in the United States.
Responsibilities
  • Develop and maintain long-term client relationships resulting in the expansion of our client base, build awareness of our company services and generate revenue.
  • Uncover immediate needs to target market through leads and follow ups, executing internal and external initiatives to drive profitable growth.
  • Support direct sales initiative by creating and participating in sales meetings and presentations.
  • Identify and attend key conferences and trade shows to increase company visibility and business opportunities.
  • Negotiate contracts and agreements.
  • Generate new leads and opportunities.
  • Develop and write proposals for submission to prospective clients.
  • Initiate and facilitate pre-work with a client as needed (e.g. CDA/NDA, MSA, SOW, meeting preparations).
  • Act as a liaison between ProPharma and potential clients (e.g., setting up capability presentations, teleconference).
  • Document leads, opportunities, proposals, and related activities in CRM.
  • Liaise with client during proposal negotiation.
  • Work closely with client-facing teams outside of the Business Development function on sales strategies based on market research and competitor analyses and execute sales plan based on those strategies.
  • Conduct sales follow-up and order close with prospective customers.
  • Work with Marketing to coordinate promotions, participate in events, and conduct follow-up contact with prospective clients.
  • Utilize internal data tracking tools to record and monitor ongoing sales activities and for producing sales metrics reports as needed.
  • Ensure communications are coordinated with internal stakeholders, and support sales plan objectives.
  • Participate in regular Business Development team meetings and meetings with key stakeholders.
  • Other duties as assigned.

ProPharma Group provides regulatory sciences consulting and related services for drugs, biologics, medical devices, and diagnostics on a global scale. Its offerings cover the full lifecycle, from early development and clinical trials to regulatory approval and post-market activities. The company’s services include regulatory sciences, clinical research, quality and compliance, pharmacovigilance, medical information, and R&D technology, delivered by a team of over 2,500 professionals with more than 20 years of operation. ProPharma Group differentiates itself by providing expert, end-to-end regulatory and life sciences solutions across multiple product types and stages, helping pharmaceutical, biotechnology, and medical device companies navigate complex regulatory and compliance challenges. The goal is to help clients bring safe and compliant products to market efficiently while maintaining ongoing lifecycle support.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Raleigh, North Carolina

Founded

2001

Simplify Jobs

Simplify's Take

What believers are saying

  • Hyderabad office opened November 2025 taps India's $130B pharma growth by 2030.
  • Dawn Sherman appointed CEO September 2024 drives global expansion strategy.
  • CF Box partnership revolutionizes cell/gene therapy manufacturing support.

What critics are saying

  • IQVIA undercuts prices, eroding ProPharma's pharmacovigilance share in 12-24 months.
  • Parexel acquisition intensifies clinical research competition in 6-12 months.
  • FDA AI tools automate 30% of submissions, reducing consulting demand in 18-36 months.

What makes ProPharma Group unique

  • ProPharma delivers end-to-end regulatory sciences across drugs, biologics, and devices.
  • Over 2,500 professionals provide pharmacovigilance and clinical research expertise.
  • Acquired Clinres Farmacija in 2024 to enhance CRO capabilities in Europe.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

24%
Pagal Parrot Media Private Limited
Dec 11th, 2025
ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands operations with new office in Hyderabad. Modern workspace supports continued growth and innovationRALEIGH, N.C., Dec. 11, 2025 /PRNewswire/ - ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, today announced the official inauguration of its new office in Hyderabad, India, on November 17, 2025. Strategically located in Mindspace, at the heart of Hyderabad's technology corridor (HITEC City/Madhapur), the new office places ProPharma among the world's leading Global Capability Centers (GCCs) in the pharmaceutical industry. Mindspace is also the first commercial business park in Hyderabad to receive a Gold rating from the Indian Green Building Council (IGBC). The prominent placement of the ProPharma logo atop the building underscores the company's growing presence and brand visibility in India.The expansion supports ProPharma's continued growth trajectory by providing capacity for additional team members across multiple service lines and creating a modern, collaborative environment designed to inspire innovation and connection. More than 70 employees participated in the inaugural celebration."This milestone represents an important step forward in ProPharma's global expansion," said Jason DeGoes, President, ProPharma. "Our new Hyderabad office strengthens our ability to deliver high-quality, integrated solutions for our clients around the world and reflects our commitment to building an exceptional environment for our teams.""We're proud to establish a world-class workspace in Hyderabad - one designed to foster creativity, efficiency, and collaboration," added Pavan Hemadri, Director of Business Operations, ProPharma. "This move enhances our ability to attract top local talent and better serve our clients across regulatory, clinical, and compliance domains."The new state-of-the-art facility features open, collaborative workspaces aligned with ProPharma's global culture of innovation and operational excellence. It also underscores ProPharma's long-term investment in India as a key hub supporting its worldwide operations.About ProPharmaFor the last 25 years, ProPharma has improved the health and wellness of patients by providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. With deep domain expertise in regulatory sciences, clinical research solutions, quality and compliance, pharmacovigilance, medical information, FSP solutions, and digital transformation, ProPharma offers an end-to-end suite of fully customizable consulting solutions that de-risk and accelerate its partners' most high-profile drug and device programs. For more information about ProPharma, please visit propharmagroup.com.About Odyssey Investment PartnersOdyssey Investment Partners is a leading private equity investment firm with more than a 25-year history of partnering with skilled managers to transform middle-market companies into more efficient and diversified businesses with strong growth profiles. Odyssey makes majority-controlled investments in industries with a long-term positive outlook and favorable secular trends. For further information about Odyssey, please visit odysseyinvestment.com.Logo - https://www.pagalparrot.com/wp-content/uploads/2025/12/ProPharma_Group_Logo.jpg View original content:https://www.prnewswire.co.uk/news-releases/propharma-expands-operations-with-new-office-in-hyderabad-302638474.html

CNHI
Oct 21st, 2024
ProPharma Appoints Brian Tuttle as Chief Financial Officer

RALEIGH, N.C., Oct. 21, 2024 /PRNewswire/ - ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, today announced that Brian Tuttle has been named Chief Financial Officer.

Kilgore News Herald
Oct 9th, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award

RALEIGH, N.C., Oct. 9, 2024 /PRNewswire/ - ProPharma, a leading global provider of regulatory, clinical, and compliance services for the life sciences industry, is pleased to announce it has won the prestigious CPHI Pharma Award for Regulatory and Compliance.

PR Newswire
Sep 30th, 2024
ProPharma Names Dawn Sherman Chief Executive Officer

RALEIGH, N.C., Sept. 30, 2024 /PRNewswire/ - ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of Odyssey Investment Partners, today announced that Dawn Sherman has been appointed Chief Executive Officer.

GlobalData
Sep 24th, 2024
Clinical Trials Arena Excellence Awards 2024: ProPharma

ProPharma, a global research consulting company headquartered in the US, has won two awards in the 2024 Clinical Trials Arena Excellence Awards, in the Business Expansion and M&A categories, celebrating its acquisition of the Croatia-based contract research organization (CRO), Clinres Farmacija.

INACTIVE